Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.5.0.2
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jul. 31, 2016
Jul. 31, 2015
Cash flows from operating activities:    
Net loss $ (35,791) $ (14,852)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization of property and equipment 1,567 1,703
Amortization of intangible assets 1,664 2,338
Fair value of acquisition-related contingent consideration 249 983
Stock-based compensation expense 1,051 1,867
Deferred income taxes 14,649 44
Other 195 58
Changes in operating assets and liabilities, excluding impact of acquisition:    
Accounts receivable 14,023 (1,147)
Unbilled receivables (565) (3,850)
Inventories 19 (732)
Prepaid expenses and other assets 1,053 (598)
Accounts payable (1,607) 1,875
Accrued expenses (5,398) (3,127)
Deferred revenues (5,419) (1,929)
Other 122 (832)
Total cash used in operating activities (14,188) (18,199)
Cash flows from investing activities:    
Purchases of property and equipment (403) (795)
Investment in capitalized software   (1,453)
Purchases of marketable securities   (2,002)
Proceeds from sale and maturity of marketable securities 252 4,003
Cash paid for acquisition of business, net of cash acquired (5,243) (11,686)
Other investing activities (83)  
Total cash used in investing activities (5,477) (11,933)
Cash flows from financing activities:    
Proceeds from issuance of common stock 33 20
Other financing activities (4)  
Total cash provided by financing activities 29 20
Effect of exchange rate changes on cash (431) 653
Net decrease in cash and cash equivalents (20,067) (29,459)
Cash and cash equivalents, beginning of period 58,733 90,019
Cash and cash equivalents, end of period 38,666 60,560
Supplemental disclosure of cash flow information:    
Income taxes paid 83 364
Supplemental disclosure of non-cash investing activities:    
Transfer of items originally classified as inventories to equipment 24 293
DCC Labs [Member]    
Supplemental disclosure of non-cash investing activities:    
Fair value of common stock issued for acquisition 2,640  
Timeline Labs [Member]    
Supplemental disclosure of non-cash investing activities:    
Fair value of common stock issued for acquisition   $ 3,025
Common Stock [Member]    
Supplemental disclosure of non-cash investing activities:    
Fair value of common stock issued for deferred stock consideration obligation $ 3,454